Comparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea

BMC Cardiovascular Disorders

Volumn 13, Issue , 2013, Pages

  Lee, Joo M ^a   Youn, Tae Jin ^b   Park, Jin J ^b   Oh, Il Young ^b   Yoon, Chang Hwan ^b   Suh, Jung Won ^b   Cho, Young Seok ^b   Cho, Goo Yeong ^b   Chae, In Ho ^b   Choi, Dong Ju ^b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Drug eluting stent; Everolimus eluting stent; Late loss; Percutaneous coronary intervention; Quantitative coronary angiography; Resolute zotarolimus eluting stent

Indexed keywords

EVEROLIMUS; ZOTAROLIMUS;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ANGIOGRAPHY DEVICE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROGNOSIS; SOUTH KOREA; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; REGISTRIES; REPUBLIC OF KOREA; SIROLIMUS; TREATMENT OUTCOME;

EID: 84883515829     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-13-65     Document Type: Article

References (20)

1. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med 2006, 354(5):483-495. 10.1056/NEJMra051091, 16452560.
2. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schomig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007, 370(9591):937-948. 10.1016/S0140-6736(07)61444-5, 17869634.
3. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007, 356(10):998-1008. 10.1056/NEJMoa067193, 17296824.
4. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009, 119(25):3198-3206. 10.1161/CIRCULATIONAHA.108.826479, 19528338.
5. Di Lorenzo E, Sauro R, Varricchio A, Carbone G, Cortese G, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, et al. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty (PASEO) randomized trial. Circulation 2009, 120(11):964-972.
6. Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, Togni M, Wenaweser P, Billinger M, Seiler C, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009, 120(5):391-399. 10.1161/CIRCULATIONAHA.109.854398, 19620501.
7. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007, 356(10):1020-1029. 10.1056/NEJMoa067731, 17296821.
8. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, Skorija K, Weber DK, Gold HK, Virmani R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005, 112(2):270-278. 10.1161/CIRCULATIONAHA.104.508937, 15998681.
9. Akin I, Schneider H, Ince H, Kische S, Rehders TC, Chatterjee T, Nienaber CA. Second- and third-generation drug-eluting coronary stents: progress and safety. Herz 2011, 36(3):190-196. 10.1007/s00059-011-3458-z, 21505934.
10. Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 2010, 363(2):136-146. 10.1056/NEJMoa1004130, 20554978.
11. Silber S, Windecker S, Vranckx P, Serruys PW. Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial. Lancet 2011, 377(9773):1241-1247. 10.1016/S0140-6736(11)60395-4, 21459430.
12. von Birgelen C, Basalus MW, Tandjung K, van Houwelingen KG, Stoel MG, Louwerenburg JH, Linssen GC, Said SA, Kleijne MA, Sen H, et al. A randomized controlled trial in second-generation zotarolimus-eluting resolute stents versus everolimus-eluting Xience V stents in real-world patients: the twente trial. J Am Coll Cardiol 2012, 59(15):1350-1361. 10.1016/j.jacc.2012.01.008, 22341737.
13. de Boer SP, Lenzen MJ, Oemrawsingh RM, Simsek C, Duckers HJ, van der Giessen WJ, Serruys PW, Boersma E. Evaluating the 'all-comers' design: a comparison of participants in two 'all-comers' PCI trials with non-participants. Eur Heart J 2011, 32(17):2161-2167. 10.1093/eurheartj/ehr126, 21565848.
14. Park KW, Lee JM, Kang SH, Ahn HS, Yang HM, Lee HY, Kang HJ, Koo BK, Cho J, Gwon HC, et al. Safety and efficacy of second-generation everolimus-eluting Xience V stents versus zotarolimus-eluting resolute stents in real-world practice: patient-related and stent-related outcomes from the multicenter prospective excellent and Resolute-Korea registries. J Am Coll Cardiol 2013, 61(5):536-544. 10.1016/j.jacc.2012.11.015, 23273394.
15. Serruys P, Foley D, De Feyter PJ. Quantitative coronary angiography in clinical practice 1994, Dordrecht, the Netherlands: Springer.
16. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115(17):2344-2351. 10.1161/CIRCULATIONAHA.106.685313, 17470709.
17. Stefanini GG, Serruys PW, Silber S, Khattab AA, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, et al. The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention). J Am Coll Cardiol 2011, 57(22):2221-2232. 10.1016/j.jacc.2011.01.036, 21616282.
18. Gu XS, Rosenbaum PR. Comparison of multivariate matching methods: structures, distances, and algorithms. J Comput Graph Stat 1993, 2(4):405-420.
19. Cohen J. Statistical power analysis for the behavioral sciences 1977, England: Lawrence Erlbaum Associates, Inc, Hillsdale NJ.
20. Pinto DS, Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Mehran R, Na Y, Turco M, et al. Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial. J Am Coll Cardiol 2006, 48(1):32-36. 10.1016/j.jacc.2006.02.060, 16814645.